These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6199499)

  • 1. Gene switching -- a new therapeutic epoch: discussion paper.
    Nalbandian RM; Cypress GC
    J R Soc Med; 1984 Mar; 77(3):217-20. PubMed ID: 6199499
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fetal hemoglobin].
    Rokicka-Piotrowicz M
    Postepy Hig Med Dosw; 1989; 43(5-6):475-97. PubMed ID: 2484927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
    Fathallah H; Sutton M; Atweh GF
    Ann N Y Acad Sci; 2005; 1054():228-37. PubMed ID: 16339670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling the fetal globin switch in man.
    Orkin SH
    Nature; 1983 Jan; 301(5896):108-9. PubMed ID: 6185847
    [No Abstract]   [Full Text] [Related]  

  • 5. 5-Azacytidine and fetal hemoglobin.
    Heller P; DeSimone J
    Am J Hematol; 1984; 17(4):439-47. PubMed ID: 6208778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal haemoglobin, sickling, and thalassaemia: a therapeutic lead?
    Br Med J; 1978 Jul; 2(6129):3-4. PubMed ID: 678797
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy to increase fetal hemoglobin in patients with sickle cell anemia.
    Platt OS
    Am J Pediatr Hematol Oncol; 1985; 7(3):258-60. PubMed ID: 2416231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
    Stamatoyannopoulos JA; Nienhuis AW
    Annu Rev Med; 1992; 43():497-521. PubMed ID: 1374600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular-genetic basis of regulation of the synthesis of individual types of hemoglobin].
    Starodub NF
    Tsitol Genet; 1980; 14(4):80-8. PubMed ID: 6160659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of hemoglobin F synthesis in patients with beta thalassemia.
    Ley TJ; Nienhuis AW
    Annu Rev Med; 1985; 36():485-98. PubMed ID: 2581500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biology of hemoglobin: its application to sickle cell anemia and thalassemia.
    Kan YW
    Schweiz Med Wochenschr Suppl; 1991; 43():51-4. PubMed ID: 1726857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin and hemoglobin switching.
    McGlave PB; Zanjani ED
    Tex Rep Biol Med; 1980-1981; 40():125-35. PubMed ID: 6172863
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of gamma-globin expression in hereditary persistence of fetal hemoglobin.
    Ottolenghi S; Nicolis S; Bertini C; Ronchi A; Crotta S; Giglioni B
    Ann N Y Acad Sci; 1990; 612():191-5. PubMed ID: 1705408
    [No Abstract]   [Full Text] [Related]  

  • 14. Progress toward increasing fetal hemoglobin production in man: experience with 5-azacytidine and hydroxyurea.
    Dover GJ; Charache S; Nora R; Boyer SH
    Ann N Y Acad Sci; 1985; 445():218-24. PubMed ID: 2409873
    [No Abstract]   [Full Text] [Related]  

  • 15. The synthesis and chemical heterogeneity of human fetal hemoglobin: overview and present concepts.
    Schroeder WA
    Hemoglobin; 1980; 4(3-4):431-46. PubMed ID: 6158499
    [No Abstract]   [Full Text] [Related]  

  • 16. The human fetal hemoglobins.
    Huisman TH
    Tex Rep Biol Med; 1980-1981; 40():29-42. PubMed ID: 6172867
    [No Abstract]   [Full Text] [Related]  

  • 17. Altering gene expression with 5-azacytidine.
    Jones PA
    Cell; 1985 Mar; 40(3):485-6. PubMed ID: 2578884
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA
    Adv Pediatr; 1996; 43():309-34. PubMed ID: 8794181
    [No Abstract]   [Full Text] [Related]  

  • 19. The association of sickle cell anemia with heterozygous and homozygous alpha-thalassemia-2: in vitro HB chain synthesis.
    Felice AE; Webber B; Miller A; Mayson SM; Harris HF; Henson JB; Gravely ME; Huisman TH
    Am J Hematol; 1979; 6(2):91-106. PubMed ID: 474574
    [No Abstract]   [Full Text] [Related]  

  • 20. alpha-Thalassemia and HbF concentration in sickle cell anemia.
    Rucknagel D; Ferrucci S; Whitten CF; Sarniak I; Odenheimer D; Sing C; Bruzdzinski C
    Prog Clin Biol Res; 1984; 165():103-20. PubMed ID: 6209727
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.